Evidence map›Paper›PMID 41422260›Full record

ArticleParasites & vectors2025

Differential effects of dual and synergist-based insecticide-treated bed nets on pyrethroid resistance and L995F/S knockdown resistance mutation dynamics in Anopheles gambiae s.l. populations in south-western Burkina Faso.

Madou Tapsoba, Wamdaogo Moussa Guelbeogo, Antoine Sanou, Soumanaba Zongo, Christelle Gogue, Siaka Debe, Kyra Arnett, Kelly Davis, Jenny Shannon, Peder Digre and 11 more

Abstract read
In one paragraph

Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Madou TapsobaCentre National de Recherche et de Formation sur le paludisme, Ouagadougou, Burkina Faso.
Wamdaogo Moussa GuelbeogoCentre National de Recherche et de Formation sur le paludisme, Ouagadougou, Burkina Faso. guelbcnrfp@yahoo.fr.
Antoine SanouCentre National de Recherche et de Formation sur le paludisme, Ouagadougou, Burkina Faso.
Soumanaba ZongoCentre National de Recherche et de Formation sur le paludisme, Ouagadougou, Burkina Faso.
Christelle GoguePATH, Washington, DC, USA.
Siaka DebeCentre National de Recherche et de Formation sur le paludisme, Ouagadougou, Burkina Faso.
Kyra ArnettPATH, Washington, DC, USA.
Kelly DavisPATH, Washington, DC, USA.
Jenny ShannonPATH, Washington, DC, USA.
Peder DigrePATH, Washington, DC, USA.
Julia MwesigwaPATH, Washington, DC, USA.
Kenzie TynuvPATH, Washington, DC, USA.
Christen FornadelInnovative Vector Control Consortium, IVCC, Liverpool, UK.
Sagnon N'FaléCentre National de Recherche et de Formation sur le paludisme, Ouagadougou, Burkina Faso.
Molly RobertsonGlobal Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.
Joseph D ChallengerMedical Research Council (MRC) Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
Gauthier TougriCentre National de Recherche et de Formation sur le paludisme, Ouagadougou, Burkina Faso.
Adama GansanéCentre National de Recherche et de Formation sur le paludisme, Ouagadougou, Burkina Faso.
Hilary RansonVector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Gnankiné OlivierUniversité Joseph KI-ZERBO, Ouagadougou, Burkina Faso.
Joseph WagmanPATH, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe introduction of next-generation insecticide-treated nets (ITNs) in Burkina Faso aims to mitigate pyrethroid resistance in malaria vectors. This study evaluated the impact of different ITN types on phenotypic resistance and kdr mutation frequencies in Anopheles gambiae sensus lacto (s.l.) populations across three health districts over 3 years.

methodsAnnual mosquito collections were conducted in Banfora (where pyrethroid-chlorfenapyr nets had been distributed), Gaoua (pyrethroid-only ITNs) and Orodara (pyrethroid-piperonyl butoxide [PBO] ITNs). Two populations were analysed: adult females collected directly from the field and those reared from field-collected larvae. World Health Organization (WHO) susceptibility bioassays measured 24-h mortality after exposure to 1×, 5× and 10× concentrations of deltamethrin and alphacypermethrin, with and without pre-exposure to piperonyl butoxide. Frequencies of kdr mutations L995F and L995S were determined by polymerase chain reaction (PCR).

resultsHigh-intensity resistance was observed in each study district, with mortality consistently below 45% and not reaching WHO thresholds even at 10× doses. PBO increased mortality, indicating metabolic resistance, but failed to restore full susceptibility. L995F predominated across all districts, years and mosquito populations. L995S remained low and variable. Pyr-only nets were associated with rising L995F frequencies and lower mortality in resistance assays. Pyrethroid (Pyr)-chlorfenapyr (CFR) nets improved mortality in resistance assays without increasing kdr prevalence. Pyr-PBO nets showed partial and inconsistent efficacy, with mosquitoes having mixed patterns in resistance assays. Similar patterns between field and laboratory-reared populations were observed.

conclusionsITN type strongly influenced resistance dynamics. Dual-active ingredient (AI) nets, particularly Pyr-CFR, appear more effective in managing resistance. Integrated resistance management combining ITN rotation, routine monitoring and complementary interventions is essential to preserve vector control efficacy.

Indexed as

AnophelesInsecticide ResistanceInsecticidesInsecticide-Treated BednetsPesticide SynergistsPyrethrinsAnimalsBurkina FasoFemaleMalariaMosquito ControlMosquito VectorsMutationNitrilesPiperonyl ButoxidedecamethrinInsecticidesNitrilesPesticide SynergistsPiperonyl ButoxidePyrethrinsAnopheles gambiae s.l.Burkina FasoDual-active-ingredient insecticidal bed netskdr mutationsPyrethroid resistance

Identifiers

PMID41422260
PMCPMC12838508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.